The Latest Cardiac and Vascular News
DUBLIN – March 4, 2019 – Medtronic plc (the “Company”) (NYSE:MDT) today announced the upsizing of the previously-announced cash tender offers by its wholly-owned subsidiaries, Medtronic, Inc. and Covidien International Finance S.A. (“CIFSA” and, together with Medtronic, Inc., the “Offerors”) for up to $1.9 billion combined aggregate purchase price (excluding accrued […]
DUBLIN – December 4, 2018 – Medtronic plc has agreed with the United States Department of Justice (DOJ) to resolve three claims against Covidien LP and ev3, Inc., now part of Medtronic. Regarding a matter concerning the Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry, […]
Updated to clarify that MDT officers and directors were compensated for excise-tax based liabilities related to stock options, and not for capital gains. Medtronic (NYSE:MDT) shareholders seeking to sue the company claiming they were harmed by its $50 billion corporate inversion merger with Covidien will get their chance in court, the […]
